This paper investigated the effects of evaluating a second magnetic-resonance imaging (MRI)-guided prostate biopsy on cancer detection rates and Gleason scores.
Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?
Schimmöller L, Quentin M, Blondin D, Dietzel F, Hiester A, Schleich C, Thomas C, Rabenalt R, Gabbert HE, Albers P, Antoch G, Arsov C
Purpose
Conclusion
Of the 54 cases of prostate cancer identified in 290 patients, two would have been missed if only one core was obtained per lesion. The Gleason score of 89% of lesions was unaffected by examination of the second core, but in 18 of the 774 lesions (2.3%) Gleason scores were upgraded from clinically insignificant to clinically significant disease (>4+3=7) after evaluation of a second core.
Studies (1)
Purpose
This study investigated the effects of evaluating a second MRI-guided prostate biopsy on cancer detection rates and Gleason scores. Two cores were obtained from 774 prostate lesions from 290 patients with a multiparametric (mp) MRI Prostate Imaging Reporting and Data System (PI-RADS) score of >III. Two transrectal, MRI-guided, in-bore biopsies were obtained using a 18G fully-automated biopsy gun. Gleason scores were determined by a single experienced pathologist. It is assumed all specimens were formalin-fixed.
Summary of Findings
The overall prostate cancer detection rates were 19% (54 of 290 patients) with detection occurring in the first core in 18% of cases (52 of 290) and in the second core in 18% of cases (53 of 290). Importantly, 2 of the 54 cases (3.7%) of prostate cancer would have been missed if only the first biopsy was obtained. When analyzed on a lesion level, 239 of 774 lesions (31%) were found to contain prostate cancer in the first core and 252 of 771 lesions (33%) contained cancer in the second core. Of the 774 lesions, 26 were found to contain prostate cancer only in the first core and 40 lesions contained prostate cancer only in the second core. The Gleason score of 89% of lesions was unaffected by examination of the second core, but Gleason scores in 2.3% of lesions were upgraded from clinically insignificant to clinically significant. As expected increasing, PI-RADS score accompanied a higher likelihood of cancer diagnosis and higher Gleason scores.
Biospecimens
TissueProstatePreservation Types
FormalinDiagnoses
NeoplasticBenignNeoplasticCarcinomaPlatforms
MorphologyH-and-E microscopyMorphologyLight microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Aliquot sequential collection 1st collection2nd collectionBiospecimen Aliquots and Components Biospecimen heterogeneity Intratumoral sampling (exact positions not specified)